Research and Markets (http://www.researchandmarkets.com/reports/c94183) has announced the addition of "Warner Chilcott Ltd: Premium Company Profile" to their offering.
Warner Chilcott is a specialty pharmaceutical company focused on two therapeutic segments: women’s health and dermatology. The company’s predecessor company was purchased by a private equity consortium in January 2005. The company has a strong portfolio of marketed and pipeline products.
Scope of this title
- Contains corporate strategy, value chain presence and SWOT Analysis
- Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
- Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights of this title
Warner Chilcott is engaged in developing, manufacturing, marketing and selling branded prescription products in women’s healthcare and dermatology. Women’s healthcare related products include Loestrin 24 FE, Ovcon 35 and Ovcon 50, Femcon FE, Estrostep FE, Femhrt and Estrace Cream and Dermatology related products include Taclonex, Dovonex and Doryx.
The company's total revenues increased at a CAGR of 34% during 2002-2006, from $235 million to $754 million. The company’s biggest contributor to revenue growth during 2002-2006 was product sales which recorded revenues of $752 million for the fiscal year 2006. The major contributors were Dovonex, Estrostep FE, Taclonex, Femhrt, and Loestrin 24 FE.
The company’s biggest contributor to sales growth out to 2010 will be the sales of Loestrin 24 FE, indicated for the prevention of pregnancy in women. Revenues from Loestrin are expected to increase at a CAGR of 59%, from $44 million in 2006 to $284 million in 2010. This represents an absolute growth of +$240 million
Key reasons to purchase this title
- Access all the important information and analysis on the company in a single report
- Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain
- Gain access to company’s adjusted five year financial data along with key ratios and market capitalization
CONTENTS:
Overview
Catalyst
Summary
Company Structure
Company Overview and Key Facts
Business Description
History
Company Financials
Stock Market Performance
P&L
Balance Sheet
Cash Flow
Products & Services
Marketed Products
Pipeline Products
Historical Product Sales
AC Forecast Product Sales
Competitors and Strategic Business Relationships
Top Competitors
Key Suppliers
Key Clients
Shareholding Structure
Strategy
Company View
Company Strategy
SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Value Chain Analysis
Discovery and Product Development
Manufacturing
Sales
Scorecard
Overview
Scorecard Analysis
Key Employees
List of Key Employees
Key Employee Biographies
Financial and Operational Overview
Financial and Operational Overview
Appendix
Ask the analyst
Our consulting
Disclaimer
TABLES AND FIGURES ALSO INCLUDED
For more information visit http://www.researchandmarkets.com/reports/c94183.
Source: Datamonitor
Research and Markets
Laura Wood
Senior Manager
Fax: +353 1 4100 980
press@researchandmarkets.com
